Agent Orange exposure may be associated with an increased risk Of biochemical progression in prostate cancer

Of 869 patients who underwent radical prostatectomy at 3 VA Medical Centers, a history of Agent Orange exposure was identified in 10% of patients.
Patients with prior Agent Orange exposure were more likely to be younger, have T1 disease, lower serum PSA levels, but similar Gleason scores. Interestingly, although agent orange exposure was not associated with an increased incidence of more advanced Gleason scores or pathologic stage, patients in this group had an independently increased risk of biochemical progression (Hazard ratio = 1.95, 95% CI 1.22 to 3.11, p = 0.005).
This study with a small sample size warrants further analysis of the impact of Agent Orange exposure in prostate cancer progression.

Share this:


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.